Pfizer's GAAP net income for 6 months of 2023 amounted to $7.894 billion, down 2.3 times from $17.781 billion in the previous year. Revenue fell 41.9% to $31.015 billion against $53.402 billion a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept